Kala Bio
(NASDAQ) KALA
Kala Bio Financials at a Glance
Market Cap
$172.05M
Revenue (TTM)
$0.00
Net Income (TTM)
$26.98M
EPS (TTM)
$-4.17
P/E Ratio
-0.04
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$0.18
Volume
3,979,098
Open
$0.19
Price
$0.18
Volume
3,979,098
Open
$0.19
Previous Close
$0.18
Daily Range
$0.17 - $0.19
52-Week Range
$0.15 - $20.60
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$0.18
Volume
3,979,098
Open
$0.19
Previous Close
$0.18
Daily Range
$0.17 - $0.19
52-Week Range
$0.15 - $20.60
KALA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kala Bio
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
David Elliot Lazar
Website
www.kalarx.comHeadquarters
Arlington, MA 02476, US
KALA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-279%
Return on Capital
-6%
Return on Assets
-3%
Earnings Yield
-25.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$172.05M
Shares Outstanding
929.49M
Volume
3.98M
Short Interest
0.00%
Avg. Volume
7.09M
Financials (TTM)
Gross Profit
$317.00K
Operating Income
$42.41M
EBITDA
$42.09M
Operating Cash Flow
$31.99M
Capital Expenditure
$15.00K
Free Cash Flow
$31.99M
Cash & ST Invst.
$7.56M
Total Debt
$0.00
Kala Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$54.00K
+21.7%
Gross Margin
0.00%
N/A
Market Cap
$172.05M
N/A
Market Cap/Employee
$4.53M
N/A
Employees
38
N/A
Net Income
$686.00K
+108.4%
EBITDA
$10.17M
-8.3%
Quarterly Fundamentals
Net Cash
$7.56M
-60.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-2.84%
N/A
Return on Invested Capital
-6.06%
N/A
Free Cash Flow
$4.57M
+2.0%
Operating Cash Flow
$4.56M
+0.9%